Skip to main content
TAVEROthe launch high street, home
AI Medical Technology logo

AI Medical Technology

Community votes
0
DR by Ahrefs
27 −1 (down) since last check

Ahrefs Domain Rating tasted 16 Nov 2026, recipe changed 2 Nov 2026.

Dermalyser is a CE-marked AI app that analyzes dermatoscopic images to support clinicians in assessing skin lesions for melanoma, delivering results in seconds

About the shop

Screenshot of the AI Medical Technology homepage

AI Medical Technology: the homepage

AI Medical Technology develops Dermalyser, an AI-powered decision-support tool for healthcare professionals assessing suspected skin melanomas. The CE-marked medical device analyzes dermatoscopic images captured via smartphone to provide clinical support in seconds, helping doctors make faster and more accurate diagnoses.

Dermalyser has been validated in prospective clinical studies showing 96% accuracy (AUC), 95% sensitivity and 85% specificity in melanoma detection. The software is designed as an assistant to clinicians, not a replacement for medical judgment—doctors retain full decision-making authority. The company reports that users experience 56% cost savings, 79% fewer referrals, and 99.5% negative predictive value.

The product is intended for licensed healthcare professionals including general practitioners, primary care physicians, and dermatologists. It has been validated for Fitzpatrick skin types I–IV and is not suitable for ulcerated lesions, very large or very small lesions, or lesions on mucous membranes, under nails, palms, soles, or near the eyes.

On the counter

  • 96% accuracy (AUC) in skin lesion assessment
  • Analysis in 5 seconds
  • 95% sensitivity and 85% specificity for melanoma
  • 99.5% negative predictive value
  • CE-marked medical device software
  • Clinician retains final diagnostic decision
  • Smartphone-based dermatoscopic image capture
  • GDPR-compliant data processing
  • EU-based secure cloud storage
  • Continuous safety and performance monitoring
Follow the specials. Log in to follow AI Medical Technology's specials

Follow AI Medical Technology: their milestones, new launches and awards come to you by email, once a day by default.

AI Medical Technology metrics

On the menu for aimedtech.com: Ahrefs Domain Rating and Majestic link data, with the change since the last tasting.

Domain Rating
27
−1 (down) since last check
Trust Flow
9
no change since last check
Citation Flow
27
no change since last check
Referring domains
67
no change since last check
External backlinks
218
no change since last check

Ahrefs Domain Rating tasted 16 Nov 2026, recipe changed 2 Nov 2026. House topic: Business (9). Majestic tasted 27 Oct 2026, recipe changed 27 Oct 2026. Majestic serves the link data. Trust Flow, Citation Flow and Topical Trust Flow are trademarks of Majestic-12 Ltd.

AI Medical Technology's address on the web

Read the web address details

We read this from the registry's RDAP record on 15 Nov 2026, 14:20 UTC.

Domain age
14 years
Registered
Expires
Registrar
Amazon Registrar, Inc.
DNSSEC
Not signed

The full slip for aimedtech.com

AI Medical Technology's street since opening

The record for AI Medical Technology after its launch on Tavero Launch (27 October 2026), from the readings we keep.

  • 27 Domain Rating (Ahrefs) no change since launch
    at launch: 27 (27 Oct 2026); latest: 15 Nov 2026
  • 9 Trust Flow (Majestic)
    first measured 27 Oct 2026
  • 67 Referring domains (Majestic)
    first measured 27 Oct 2026

Day 20 since launch. Next receipt: day 30, 26 Nov 2026. The figures report a change; they do not say what caused it, and many things can. No figure here is a guess.

Biggest gains on Tavero Launch

Launching your own product?

Free tips from Tavero Launch for getting ready, launch day, the week after and what to do next.

  • Before the day
  • Launch day
  • Rest of the week
  • What comes next
Read the playbook

Ask at the counter

What is Dermalyser?

Dermalyser is a CE-marked software that uses artificial intelligence to analyze digital dermatoscopic images of skin lesions and functions as a decision-support tool for healthcare professionals when assessing suspected skin melanomas.

Does Dermalyser replace a dermatologist?

No. Dermalyser is a decision-support tool and the final diagnosis is always made by healthcare professionals. The clinical judgment always takes precedence.

What skin types has Dermalyser been validated for?

Dermalyser has been validated for patients with Fitzpatrick skin types I–IV.

How long does an analysis take?

An analysis typically takes only a few seconds once the image is captured.

What are the clinical validation results?

Clinical validation studies show high accuracy for all melanomas (AUC 0.96) and even higher for invasive melanomas (AUC 0.988), with very good sensitivity (95.2% and 100%, respectively) and specificity (84.5% and 92.6%, respectively).

Leave a review for AI Medical Technology

Your rating

No one has reviewed AI Medical Technology at the counter yet. Be first. A review is on the house. You can't buy one.

Read the counter talk

More on this profile

AI Medical Technology has a free listing. The owner can unlock the full profile with a paid launch for $5:

  • Founder story (locked)
  • Milestones (locked)
  • Demo video (locked)
  • Dofollow website link (locked)

Other shops on this street

Ask a question